Latest news for Gauzy (NASDAQ:GAUZ) Stock

Gauzy

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.

Gauzy Ltd

Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) has engaged the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) amid ongoing investigations into the company <a target="_blank" href="https://www.benzinga.com/general/biotech/23/10/35237906/alzheimers-focused-cassava-sciences-faces-controversy-as-key-collaborator-accused-of-scientific-m" rel="noreferrer noopener">and two senior employees</a>.
Cassava&#8217;s board formed an Ad Hoc Investigation Committee to oversee outside counsel conducting the investigation. The Committee also oversees the company&#8217;s disclosures related to the investigation, the company <a href="https://www.benzinga.com/secfilings/24/07/39572761/cassava-sciences-inc-general-corporate-statement-form8" target="_blank" rel="noreferrer noopener">said</a> in an SEC filing.
On Friday, the DOJ announced an indictment against Dr. Hoau-Yan Wang, alleging he submitted fraudulent grant applications to the <a href="https://www.benzinga.com/news/24/06/39557467/cassava-shares-are-down-over-30-heres-why" target="_blank" rel="noreferrer noopener">National Institutes of Health</a>.
The indictment claims Dr. Wang made false statements about the mechanism of simufilam and manipulated research results, including <a target="_blank" href="https://www.benzinga.com/general/biotech/23/10/35237906/alzheimers-focused-cassava-sciences-faces-controversy-as-key-collaborator-accused-of-scientific-m" rel="noreferrer noopener">fabricating Western Blot images</a>.
Dr. Wang, a professor at the City University of New York, was a former scientific collaborator and advisor to Cassava. His research, alongside Dr. Lindsay Burns, Cassava&#8217;s SVP of Neuroscience, led to the discovery of simufilam.
Dr. Wang&#8217;s lab conducted the final bioanalysis for the Phase 2b study. He received a monthly stipend of $2,000 and stock options for his consulting work with Cassava, which were terminated before his indictment.
Cassava&#8217;s ongoing internal investigation has revealed the potential unblinding of some Phase 2b study participants due to an email sent by a senior employee.
The Phase 2b study aimed to measure changes in cerebrospinal fluid (CSF) biomarkers and cognitive outcomes using the Cambridge Neuropsychological Test Automated Battery over 28 days.
Cassava reported significant improvements in biomarkers based on Dr. Wang&#8217;s bioanalysis. However, the cognition portion of the study, analyzed for effect size rather than statistical significance, excluded certain participants.
Despite the controversy, Cassava is proceeding with two Phase 3 clinical trials of simufilam, both fully enrolled with about 1,900 patients. Data and samples from these trials will be analyzed by independent firms, with no involvement from Dr. Wang or his lab.
Price Action: SAVA shares are down 7.69% at $11.40 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/03/37605163/alzheimers-drug-trial-results-questioned-after-damning-fda-inspection-report" target="_blank" rel="noreferrer noopener">Alzheimer&#8217;s Drug Trial Results Questioned After &#8216;Damning&#8217; FDA Inspection Report</a>.</li>
</ul>

Biotech

Government

News

Health Care

Legal

Movers

Trading Ideas

General

SAVA

Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation

Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) has signed a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39572726/snapdragon-unveiled-on-manchester-united-kits" rel="noreferrer noopener">new sponsorship deal</a> to become the front-of-shirt sponsor for Manchester United Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) Football Club.
The company aims to increase awareness of its Snapdragon brand as it expands into personal computing.
The California-based chipmaker is leveraging its new partnership with one of the most recognized clubs in the world&#8217;s most popular sport.
One home game for the U.K. Premier League team provides Snapdragon with exposure comparable to a Super Bowl ad, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-07-01/qualcomm-sponsors-manchester-united-amid-bigger-consumer-pc-push?srnd=technology-vp&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Snapdragon, known for its association with smartphone processors, is now poised to play a more prominent role as Qualcomm intensifies efforts to penetrate the PC industry.
This endeavor positions Qualcomm against Intel Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) long-standing &#8216;Intel Inside&#8217; marketing campaign.
While neither Qualcomm nor Manchester United disclosed the sponsorship deal&#8217;s value, Bloomberg reported last year that it is <a target="_blank" href="https://www.benzinga.com/news/large-cap/23/09/34530955/manchester-united-scores-big-with-qualcomm-60m-per-year-game-changer" rel="noreferrer noopener">worth over $76 million</a> (60 million Pounds) annually.
This figure surpasses the roughly 47 million Pounds paid by the previous sponsor, German software company TeamViewer SE.
The three-year agreement, with an option for two additional years, allows the football club to utilize Qualcomm&#8217;s technology to enhance fan experiences. The club boasts over 1 billion followers worldwide.
Price Actions: QCOM shares are down 0.47% at $198.25 at the last check Monday. MANU shares are up 0.53% at $16.23.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Company

Media

INTC

MANU

QCOM

Qualcomm Becomes Manchester United's Front-of-Shirt Sponsor - What's Going On?

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) with a Overweight and maintains $160 price target.

Price Target

Reiteration

Analyst Ratings

Cantor Fitzgerald Reiterates Overweight on Novo Nordisk, Maintains $160 Price Target

Nikola Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) shares are trading at new all-time lows Monday as the stock moves lower on continued downward momentum <a href="https://www.benzinga.com/news/24/06/39541409/nikola-delivers-hydrogen-fuel-cell-electric-semi-truck-to-walmart-canada">following a reverse split last week.&nbsp;</a>
The Details:
Last week, Nikola effected a 1-for-30 <a href="https://www.benzinga.com/news/24/06/39486385/whats-going-on-with-nikola-stock-after-its-reverse-split">reverse stock split </a>in order to regain compliance with Nasdaq's continued listing requirements.&nbsp;
According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, shares are trading well-below the stock&#8217;s 50-day moving average of $15.74 and is marking new all-time lows on Monday.&nbsp;
Nikola announced last Thursday <a href="https://www.nikolamotor.com/walmart-canada-becomes-the-first-major-retailer-in-canada-to-introduce-a-hydrogen-fuel-cell-electric-semi-truck">it has delivered</a> a hydrogen fuel cell-powered electric semi-truck to Walmart Canada which will be deployed in Ontario for longer-haul trips.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/06/39554711/lululemon-stock-dips-after-nikes-q4-report-whats-going-on">Lululemon Stock Dips After Nike&#8217;s Q4 Report: What&#8217;s Going On?</a>&nbsp;
&#8220;This is a first for a retailer in Canada and is an example of how we will continue to push forward, embrace new technology and spark change within the industry,&#8221; Walmart Canada CEO Gonzalo Gebara said.&nbsp;
The Class 8 vehicle has a range of about 800 kilometers and, on average, can avoid 97 metric tons of CO2 tailpipe emissions annually, Nikola said.&nbsp;
A Reuters report said Nikola may benefit from Tesla's slow ramp up in <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39563174/tesla-rises-ahead-of-crucial-q2-deliveries-rivian-affirms-goal-after-volkswagen-dea">production of Tesla Semis</a>. The Elon Musk-led company is having difficulty meeting demands of customers including PepsiCo. and Walmart.
<h2 class="wp-block-heading">Will NKLA Stock Go Up?</h2>
When trying to assess whether or not Nikola will trade higher from current levels, it's a good idea to take a look at analyst forecasts. 
Wall Street analysts have an average 12-month price target of $1 on Nikola. In the last month, one analyst has adjusted price targets. Here's a look at recent price target changes <a href="https://www.benzinga.com/quote/NKLA/analyst-ratings">[Analyst Ratings]</a>. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Nikola have performed in recent history. 
Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Nikola is 81.63% down year-to-date. The average analyst price target suggests the stock could have further downside ahead.
For a broad overview of everything you need to know about Nikola, visit <a href="https://www.benzinga.com/quote/NKLA">here</a>. If you want to go above and beyond, there's no better tool to help you do just that than <a href="https://pro.benzinga.com/">Benzinga Pro</a>. Start your free trial today.
NKLA Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Nikola shares are down 7.08% at $7.61 at the time of publication Monday.
Read Also: <a href="https://www.benzinga.com/news/24/06/39554543/why-psychedelic-pharma-clearmind-medicine-stock-is-moving-higher">Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher</a>
Image: Courtesy of Nikola Corporation

NKLA

EV-Maker Nikola's Stock Hits New All-Time Low: What's Going On?

High-rolling investors have positioned themselves bearish on Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SE often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 16 options trades for Sea. This is not a typical pattern.
The sentiment among these major traders is split, with 25% bullish and 43% bearish. Among all the options we identified, there was one put, amounting to $40,480, and 15 calls, totaling $1,169,014.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $80.0 for Sea over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Sea's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Sea's whale trades within a strike price range from $45.0 to $80.0 in the last 30 days. 
<h3>Sea Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1719846993_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$26.6</td>
<td>$24.85</td>
<td>$25.85</td>
<td>$45.00</td>
<td>$385.1K</td>
<td>2.7K</td>
<td style="text-align: right;">151</td>
</tr>
<tr>
<td>SE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$26.95</td>
<td>$26.35</td>
<td>$26.35</td>
<td>$45.00</td>
<td>$211.0K</td>
<td>2.7K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>SE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/19/24</td>
<td>$2.13</td>
<td>$2.07</td>
<td>$2.07</td>
<td>$68.00</td>
<td>$103.5K</td>
<td>4</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>SE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/19/24</td>
<td>$2.01</td>
<td>$1.94</td>
<td>$2.02</td>
<td>$68.00</td>
<td>$70.8K</td>
<td>4</td>
<td style="text-align: right;">545</td>
</tr>
<tr>
<td>SE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.25</td>
<td>$17.85</td>
<td>$17.9</td>
<td>$70.00</td>
<td>$44.7K</td>
<td>925</td>
<td style="text-align: right;">204</td>
</tr>
</tbody>
</table>

<h3>About Sea</h3>
Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value and number of transactions. Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce, which is now the main growth driver. Shopee is a hybrid C2C and B2C marketplace platform operating in eight core markets. Indonesia accounts for 35% of GMV, with the rest split mainly among Taiwan, Vietnam, Thailand, Malaysia, and the Philippines. For Garena, Free Fire was the most downloaded game in January 2022 and accounted for 74% of gaming revenue in 2021. Sea's third business, SeaMoney, provides mostly credit lending.
In light of the recent options history for Sea, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Sea</h3>
<ul>
<li>Currently trading with a volume of 3,872,958, the SE's price is down by -4.34%, now at $68.32. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 43 days.</li>
</ul>
<h3>What Analysts Are Saying About Sea</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $82.33333333333333.
<ul>
<li>Maintaining their stance, an analyst from Loop Capital continues to hold a Buy rating for Sea, targeting a price of $94. </li>
<li>Reflecting concerns, an analyst from DBS Bank lowers its rating to Hold with a new price target of $75.</li>
<li>An analyst from JP Morgan has revised its rating downward to Neutral, adjusting the price target to $78. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Sea options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Check Out What Whales Are Doing With Sea

Financial giants have made a conspicuous bearish move on Bank of America. Our analysis of options history for Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) revealed 13 unusual trades.
Delving into the details, we found 30% of traders were bullish, while 69% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $452,295, and 8 were calls, valued at $504,945.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $28.0 to $47.0 for Bank of America during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bank of America's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bank of America's significant trades, within a strike price range of $28.0 to $47.0, over the past month.
<h3>Bank of America 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1719846988_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$0.81</td>
<td>$0.79</td>
<td>$0.8</td>
<td>$40.00</td>
<td>$179.9K</td>
<td>10.1K</td>
<td style="text-align: right;">453</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.45</td>
<td>$3.4</td>
<td>$3.4</td>
<td>$40.00</td>
<td>$159.8K</td>
<td>64.2K</td>
<td style="text-align: right;">98</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$7.45</td>
<td>$7.35</td>
<td>$7.45</td>
<td>$47.00</td>
<td>$100.5K</td>
<td>371</td>
<td style="text-align: right;">82</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.9</td>
<td>$4.8</td>
<td>$4.9</td>
<td>$37.00</td>
<td>$73.5K</td>
<td>8.2K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$0.08</td>
<td>$0.07</td>
<td>$0.08</td>
<td>$36.00</td>
<td>$66.4K</td>
<td>16.3K</td>
<td style="text-align: right;">2</td>
</tr>
</tbody>
</table>

<h3>About Bank of America</h3>
Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
After a thorough review of the options trading surrounding Bank of America, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Bank of America</h3>
<ul>
<li>Currently trading with a volume of 9,553,598, the BAC's price is up by 0.23%, now at $39.86. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 15 days.</li>
</ul>
<h3>Professional Analyst Ratings for Bank of America</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $41.5.
<ul>
<li>An analyst from Keefe, Bruyette &amp; Woods has elevated its stance to Outperform, setting a new price target at $46. </li>
<li>An analyst from Piper Sandler persists with their Underweight rating on Bank of America, maintaining a target price of $37. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bank of America options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

A Closer Look at Bank of America's Options Market Dynamics

Deep-pocketed investors have adopted a bullish approach towards PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PYPL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for PayPal Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 30% bearish. Among these notable options, 3 are puts, totaling $371,150, and 7 are calls, amounting to $909,280.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $90.0 for PayPal Holdings during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of PayPal Holdings stands at 2529.38, with a total volume reaching 2,560.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in PayPal Holdings, situated within the strike price corridor from $50.0 to $90.0, throughout the last 30 days.
<h3>PayPal Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1719846983_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.75</td>
<td>$55.00</td>
<td>$498.7K</td>
<td>901</td>
<td style="text-align: right;">65</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$5.15</td>
<td>$4.95</td>
<td>$4.95</td>
<td>$52.50</td>
<td>$185.6K</td>
<td>2.6K</td>
<td style="text-align: right;">825</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$7.5</td>
<td>$7.2</td>
<td>$7.46</td>
<td>$90.00</td>
<td>$149.0K</td>
<td>4.6K</td>
<td style="text-align: right;">4</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$11.2</td>
<td>$11.1</td>
<td>$11.12</td>
<td>$50.00</td>
<td>$99.0K</td>
<td>5.9K</td>
<td style="text-align: right;">327</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.8</td>
<td>$8.6</td>
<td>$8.6</td>
<td>$60.00</td>
<td>$98.9K</td>
<td>2.2K</td>
<td style="text-align: right;">11</td>
</tr>
</tbody>
</table>

<h3>About PayPal Holdings</h3>
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 426 million active accounts at the end of 2023. The company also owns Venmo, a person-to-person payment platform.
After a thorough review of the options trading surrounding PayPal Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is PayPal Holdings Standing Right Now?</h3>
<ul>
<li>With a volume of 3,771,574, the price of PYPL is up 0.45% at $58.29. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 30 days.</li>
</ul>
<h3>Professional Analyst Ratings for PayPal Holdings</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $76.4.
<ul>
<li>An analyst from RBC Capital downgraded its action to Outperform with a price target of $84. </li>
<li>An analyst from Keefe, Bruyette &amp; Woods has revised its rating downward to Outperform, adjusting the price target to $78. </li>
<li>An analyst from Citigroup has decided to maintain their Buy rating on PayPal Holdings, which currently sits at a price target of $81. </li>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for PayPal Holdings, targeting a price of $70. </li>
<li>An analyst from Goldman Sachs has revised its rating downward to Neutral, adjusting the price target to $69. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PayPal Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

PYPL

Behind the Scenes of PayPal Holdings's Latest Options Trends

Reliance Global Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares are trading higher Monday. The stock began trading on a 1-for-17 reverse split-adjusted basis at <a href="https://www.benzinga.com/pressreleases/24/06/g39502076/reliance-global-group-announces-reverse-stock-split">Monday's opening bell.&nbsp;</a>
What To Know:
Reliance Global also announced <a href="https://www.benzinga.com/pressreleases/24/07/g39573438/reliance-global-group-announces-formation-of-new-real-estate-division-aimed-at-expanding-operation">the creation</a> of a new Real Estate division intended to supplement, and not replace, its focus on acquiring accretive and cash flow positive insurance agencies. Reliance said it plans to launch the real estate division following the completed <a href="https://www.benzinga.com/pressreleases/24/06/g39377501/reliance-global-group-provides-update-on-pending-spetner-acquisition">acquisition</a> of Spetner Associates, expected to close in the second half of 2024.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/06/39554711/lululemon-stock-dips-after-nikes-q4-report-whats-going-on">Lululemon Stock Dips After Nike&#8217;s Q4 Report: What&#8217;s Going On?</a>&nbsp;
&#8220;We are excited to launch a significant initiative—a new division within Reliance dedicated to the acquisition and development of multi-family and commercial real estate properties. We are also pleased to announce that Abe Miller will be joining the Company to head this division and provide strategic guidance on our future real estate endeavors," commented Ezra Beyman, CEO of Reliance.
<h2 class="wp-block-heading">Should I Sell My RELI Stock? </h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of Reliance Global Group have lost 95.09% year to date. This compares to the average annual return of -83.95%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Reliance Global Group stock currently has an RSI of 37.95, indicating neutral conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
RELI Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Reliance Global Group shares are up 10% at $4.23 at the time of publication Monday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/06/39554543/why-psychedelic-pharma-clearmind-medicine-stock-is-moving-higher">Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher</a></li>
</ul>
Image: Shutterstock

RELI

What's Going On With Reliance Global Stock After Its Reverse Split?

Goldman Sachs analyst Kash Rangan maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and maintains $220 price target, Added to Conviction List

SNOW

Goldman Sachs Maintains Buy on Snowflake, Maintains $220 Price Target, Adds to Conviction List

Senti Biosciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) shares are trading higher by 102.6% to $0.56 during Monday&#8217;s session after the company was awarded $8 million from the California Institute for Regenerative Medicines, which will support the <a href="https://www.benzinga.com/pressreleases/24/07/g39572942/senti-bio-awarded-california-institute-for-regenerative-medicines-cirm-grant-for-clinical-developm">ongoing development of SENTI-202</a>.
The company says SENTI-202 is an investigational cell therapy for treating relapsed/refractory hematologic malignancies, including acute myeloid leukemia (AML). The ongoing Phase 1 trial aims to provide initial efficacy data by the end of 2024 and durability data in 2025.
Timothy Lu, CEO and Co-Founder of Senti Bio, expressed gratitude for CIRM&#8217;s support, highlighting SENTI-202&#8217;s potential to improve AML treatment. The trial, enrolling adult patients with specific hematologic malignancies in the US and Australia, evaluates two dose levels of SENTI-202 cells administered in cycles after disease-specific conditioning.
Read Also: <a href="https://www.benzinga.com/news/24/07/39575189/whats-going-on-with-gamestop-stock-monday">What&#8217;s Going On With GameStop Stock Monday?</a>
<h2 class="wp-block-heading">Is SNTI A Good Stock To Buy?</h2>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/SNTI">Senti Biosciences</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 14.97%, you'll need to buy a share of Global Net Lease by the Jul. 11, 2024. Once done, you can expect to receive a nominal payout of $0.28 on Jul. 16, 2024.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/SNTI">Senti Biosciences</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SNTI has a 52-week high of $1.09 and a 52-week low of $0.21.

SNTI

Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening?

Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price rebound prompted mixed reactions from traders and technical analysts about the apex crypto&#8217;s <a href="https://www.benzinga.com/money/bitcoin-price-prediction">near-term prospects</a>.
What Happened: Prominent crypto trader DonAlt <a href="https://x.com/CryptoDonAlt/status/1807686248380653928">noted</a> that Bitcoin has almost closed above support, stating "This is so close it just adds a bunch of ambiguity, not great if you want actionable signals from the market."
He sees the weekly close as a really bad bearish retest.
Another trader compared the current Bitcoin scenario with the third quarter in 2023, highlighting that there are two major retests of key support after "months of consolidation below key resistance." He notes key resistance levels at $30,000 in 2023 and $70,000 now.
Jelle <a href="https://x.com/CryptoJelleNL/status/1807703467185644024">concluded</a>, "If the coming months play out similarly too &#8211; we&#8217;re in for more boredom before the inevitable moon mission starts."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a>&#39;s weekly RSI midlevel &#8212; dynamic support and resistance. Keep it simple. <a href="https://t.co/CTCuEgIAPC">pic.twitter.com/CTCuEgIAPC</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1807771543314809197?ref_src=twsrc%5Etfw">July 1, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39573649/hothead-investor-shares-7-month-update-on-maxing-out-8-credit-cards-to-buy-bitcoin">Hothead Investor Shares 7-Month Update On &#8216;Maxing Out 8 Credit Cards To Buy Bitcoin&#8217;</a>
Why It Matters: While Bitcoin's price action remained volatile over the weekend, Monday commenced with price pushing above the $63,000 mark. Last Friday, <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39573821/why-is-bitcoin-up-on-monday">Bitcoin spot ETFs</a> saw inflows of $73 million, the highest in two weeks.
IntoTheBlock data notes Bitcoin's large transaction volume dropping by 16% and exchanges&#8217; netflows by 114.6%. Around 88% of Bitcoin holders are currently in profit, a higher number than the week prior.
What&#8217;s Next: The influence of <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a> is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Image created using artificial intelligence with Midjourney.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39573821/why-is-bitcoin-up-on-monday">Why Is Bitcoin Up On Monday?</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

What Do Traders Expect From Bitcoin In Q3?

Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) stock is trending on Monday. E.L.F Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) expanded its collaboration with the video <a href="https://www.benzinga.com/news/24/07/39568264/e-l-f-expands-roblox-collaboration-launches-real-world-commerce">game company.</a>
The Details: E.L.F Beauty added a digital storefront in its e.l.f. UP! experience on Roblox where it will test selling real-world merchandise.
U.S. visitors through the virtual kiosk can purchase a limited-edition Pets Hoodie, celebrating E.L.F&#8217; Beauty&#8217;s cruelty-free stance. Visitors can also purchase lip balm, lip oils, and sunscreen through the kiosk.
The e.l.f. UP! experience was originally introduced in November 2023 and currently has a 96% positivity rating.
&#8220;Our vision is to ultimately enable brands and creators to turn their incredible brand affinity and user engagement on the platform into a seamless shopping experience for their new and existing audiences,&#8221; said Stephanie Latham, vice president of global brand partnerships at Roblox. 
See Also: <a href="https://www.benzinga.com/general/entertainment/24/06/39555552/rockstar-games-co-founder-reveals-why-gta-movie-never-made-sense">Rockstar Games Co-Founder Reveals Why GTA Movie &#8216;Never Made Sense&#8217;</a>
RBLX Price Action: At the time of writing, Roblox stock is trading 2.02% lower at $36.46 per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock

RBLX

What's Going On With Roblox Shares Monday?

<a href="https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_07012024_DYAI_Vandermosten.pdf" title="https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_07012024_DYAI_Vandermosten.pdf">https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_07012024_DYAI_Vandermosten.pdf</a>

DYAI

Watching Dyadic International; Zacks Small-Cap Research Gives Stock $9 Price Valuation

French drugmaker Sanofi is poised to commit between 1.3 billion euros and 1.5 billion euros ($1.4 billion &#8211; $1.6 billion) to enhancing its insulin production site in Frankfurt, Germany.
The site in Frankfurt&#8217;s Hoechst district is known for producing the company&#8217;s insulin brand, Lantus.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/05/38970075/hawaii-court-rules-against-bristol-myers-sanofi-in-blood-clot-drug-case-increases-liability-to-91" rel="noreferrer noopener">Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M</a>.
This move comes after initial plans to shift Lantus production to France were reconsidered.
The decision to invest in the Frankfurt site represents a significant victory for Germany&#8217;s healthcare sector.
Germany&#8217;s ruling coalition has been actively working to attract healthcare investments. In February, Daiichi Sankyo announced plans to spend around 1 billion euros to advance its precision cancer drug work near Munich.
Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) also committed 2.3 billion euros last November to produce obesity and diabetes medications in Germany.
Sanofi&#8217;s investment is expected to bolster its production capabilities and reinforce its commitment to maintaining a strong manufacturing presence in Germany.
Reuters noted that the upgrade will likely enhance Lantus&#8217;s supply chain stability and support Sanofi&#8217;s long-term strategic goals.
In May, Sanofi announced an&nbsp;investment of more than €1 billion to create new bioproduction capacity&nbsp;at its French sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime), <a target="_blank" href="https://www.benzinga.com/markets/eurozone/24/05/38794261/healthcare-giants-pfizer-astrazeneca-sanofi-inject-over-2b-to-boost-frances-healthcare-sector" rel="noreferrer noopener">and Lyon Gerland (Rhône)</a>.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/06/39502197/sanofi-looks-to-sell-20b-icy-hot-division-likely-bidders-include-advent-pai-partners-blackstone-c" target="_blank" rel="noreferrer noopener">Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC</a>.</li>
</ul>
Price Action: At the last check on Monday, SNY shares were up 1.96% at $49.47.
Image by HJBC via Shutterstock

Large Cap

Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant

Goldman Sachs analyst Will Nance maintains Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) with a Buy and maintains $43 price target, Added to Conviction List&nbsp;

GLBE

Goldman Sachs Maintains Buy on Global E Online, Maintains $43 Price Target, Adds to Conviction List

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with a Overweight and maintains $885 price target.

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target

The Supreme Court has decided not to rule on the constitutionality of laws passed in Texas and Florida that aimed to prevent <a href="https://www.benzinga.com/topic/social-media">social media companies</a> from banning users based on their political views.
What Happened: The Supreme Court, on Monday, vacated lower court rulings on the Texas and Florida laws, The Hill <a href="https://thehill.com/regulation/court-battles/4749570-supreme-court-punts-on-texas-florida-social-media-laws/">reported</a>. The laws were designed to prevent social media companies from banning users based on their political views, a move that could have significantly impacted the companies&#8217; ability to enforce their own rules and the concept of free speech online.
Justice Elena Kagan, writing for the majority, stated the lower courts had not properly considered the nature of the challenge to the laws. The decision leaves in place lower court injunctions that have prevented the laws from being enforced.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39437268/the-rise-and-fall-of-pioneering-weed-markets-rip-california-and-colorado-cannabis-industries?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">The Rise And Fall Of Pioneering Weed Markets: RIP California And Colorado Cannabis Industries</a>
The laws were passed in 2021 in response to Republican criticism of how social media companies enforced their policies, particularly in relation to bans and suspensions of prominent conservative figures, according to The Hill.
Why It Matters: The laws in Texas and Florida were part of a broader debate about the role of social media companies in regulating content, with major <a href="https://www.benzinga.com/markets/equities/24/02/37353082/the-supreme-court-is-weighing-whether-the-first-amendment-should-apply-to-meta-youtube-other-soc">implications for companies</a> like Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) YouTube.
The decision not to rule on the Texas and Florida laws suggests that this debate is far from over and that the Supreme Court may need to address the issue of social media regulation more broadly in the future.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/markets/equities/24/06/39566797/roaring-kitty-keith-patrick-gill-accused-of-gamestop-pump-and-dump-scheme-in-class-action-lawsui?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Roaring Kitty&#8217; Keith Patrick Gill Accused Of Gamestop Pump-And-Dump Scheme In Class Action Lawsuit</a></li>
</ul>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Shutterstock.

Social Media

Politics

GOOG

GOOGL

Supreme Court Refuses To Rule On Texas, Florida Social Media Laws, Leaves First Amendment Challenge For Later

Chinese stocks <a href="https://www.benzinga.com/markets/asia/24/07/39570865/tiktok-and-social-media-influencers-drive-gen-zs-shopping-habits-in-asia-pacific-report">improved on Monday </a>after data on June manufacturing came in better than forecast and reached its highest point in three years.
The CSI 300 Index, which follows China&#8217;s largest companies listed in Shanghai and Shenzhen, rise 0.5% on Monday to come out of a four-month low and build on Friday&#8217;s 2% gain, the South China Morning Post <a href="https://www.scmp.com/business/markets/article/3268734/chinas-stock-index-jumps-3-year-high-after-junes-factory-data-surpassed-expectations">reported</a>. Hong Kong's financial markets were closed for a holiday.
Japan's Nikkei 225 edged up 0.1%, while South Korea's Kospi gained 0.2% yet Australia's S&amp;P/ASX 200 declined 0.2%.
The Caixin/S&amp;P Global manufacturing purchasing managers' index (PMI) improved from 51.7 in May to to 51.8 in June to set the fastest pace since May 2021 and beat analysts' forecasts of 51.2, according to the Morning Post.
The upbeat private data quelled concerns following&nbsp;official PMI data, which came in at 49.5 in June and was unchanged from May, according to National Bureau of Statistics data released on Sunday. A reading above 50 indicates expansion of activity, while a reading below suggests contraction.
Also Read:<a href="https://www.benzinga.com/markets/asia/24/07/39567244/chinas-central-bank-could-embrace-federal-reserve-model-in-a-major-reform-under-governor-pan-gongshe"> China&#8217;s Central Bank Could Embrace Federal Reserve Model In A Major Reform Under Governor Pan Gongsheng</a>
Property developer stocks went up in mainland China on hopes that a positive economic climate would entice buyers back to the real estate market. 
Poly Developments and Holdings Group Co., Ltd. jumped 6.2% to 9.31 yuan and China Vanke Co. Ltd. rallied 5.2% to 7.29 yuan. Chip designer Cambricon Technologies rose 3.1% to 204.84 yuan and electronics product maker Foxconn Industrial Internet (601138.SS) ticked up 2.2% to 28 yuan.
Renewed market intervention efforts from "the national team" as indicated by a surge in net assets of the nation's biggest exchange-traded funds has also buoyed sentiment.
A total of 51.1 billion yuan (US$7 billion) came into the market through CSI 300 ETF in the week ended June 28 after the Shanghai Composite Index slipped below the 3,000 psychological level, Morning Post reported , as cited in state-run Securities Times on Monday, Morning Post reported.
Price Action: Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) rose 0.24% to $72.17, Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) gained 0.47% to $81.89 and NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) improved 4.84 % to $4.36.
KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>) gained 0.43% as iShares MSCI China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NASDAQ">MCHI</a>) rose 0.62% and iShares China Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>) went up 0.54%.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/24/06/39543115/chinese-automakers-to-grab-33-of-global-market-share-by-2030-even-after-us-and-eu-tariffs-report">Chinese Automakers To Grab 33% Of Global Market Share By 2030 Even After US And EU Tariffs: Report</a></li>
</ul>

Asia

Emerging Markets

BABA

BIDU

KWEB

MCHI

Chinese Markets Pick Up Following Positive Data On Manufacturing

On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) was awarded an Other Transaction Agreement (OTA) with a potential value of up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g39572562/tonix-pharmaceuticals-awarded-up-to-34-million-u-s-department-of-defense-contract-for-accelerated-" rel="noreferrer noopener">Department of Defense (DoD)</a>.
According to data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>, the shares are trading on a strong session volume of 5.74 million and have a market cap of $4.9 million.
The contract&#8217;s objective is to develop small-molecule broad-spectrum antiviral agents for the prevention or treatment of infections, improving the medical readiness of military personnel in biological threat environments.
Tonix&#8217;s program will focus on optimizing and developing its TNX-4200 program to develop an orally available CD45 antagonist with broad-spectrum efficacy against a range of viral families through preclinical evaluation.
The program is expected to establish physicochemical properties, pharmacokinetics, and safety attributes to support an Investigational New Drug submission and fund a first-in-human Phase 1 clinical study.
&#8220;Through our agreement with DTRA, our broad-spectrum antiviral research program will address the DoD&#8217;s goal of protecting U.S. Joint Forces in the event biological weapons are introduced onto the battlefield,&#8221; said Seth Lederman, President and CEO of Tonix.
&#8220;The DoD announced in December 2022 that they are moving beyond a &#8216;one bug, one drug&#8217; approach and are seeking broad-spectrum drugs since one cannot predict which or how many viruses may be deployed. This funding provides important validation for our ongoing research and current in-house capabilities and will enable Tonix to advance its antiviral discovery program.&#8221;
This program has the potential to reduce viral load and allow the adaptive immune system to alert the other arms of the immune system to mount a protective response.
Tonix plans to leverage previous research on phosphatase inhibitors, specifically compounds that target CD45, to optimize lead compounds for therapeutic intervention of biothreat agents and provide the government with a complete and cost-effective solution for a broad-spectrum medical countermeasure.
Tonix&#8217;s premise is that partial inhibition of CD45 will provide optimal antiviral protection while requiring lower plasma drug concentrations, a lower dose, and a better safety profile.
Tonix will utilize its research laboratory capabilities at its research and development center in Frederick, Md., as well as experienced personnel in-house.
Price Action: TNXP shares are up 3.34% at $0.72 at last check Monday. During premarket trading, shares reached as high as 0.91.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/06/39328746/this-biopharma-stock-is-trading-23-higher-in-pre-market-after-wrapping-up-4m-public-offering" target="_blank" rel="noreferrer noopener">This Biopharma Stock Is Trading 23% Higher In Premarket After Wrapping Up $4M Public Offering</a>.</li>
</ul>

Contracts

TNXP

Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract

Goldman Sachs analyst Michael Ng maintains Fox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) with a Buy and maintains $42 price target, Added to Conviction List&nbsp;

FOXA

Goldman Sachs Maintains Buy on Fox, Maintains $42 Price Target, Adds to Conviction List

Gauzy Ltd. Aims For U.S. IPO As Revenue Grows

U.S. IPO Weekly Recap: 2 Sizable Deals Price Up And Trade Up, While Broader IPO Market Slides

Investors Prep For A Key Jobs Report

Wall Street Breakfast: The Week Ahead

IPO roundup: Novelis, Waystar Holding, and more

U.S. IPO Weekly Recap: Healthcare Software Leads $1.3 Billion IPO Week, Even As Novelis Calls Off IPO

Matthew Sheerin, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Gauzy Ltd. (GAUZ). Matthew Sheerin has given his Buy rating due...

Buy Rating Affirmed for Gauzy Ltd. on Strong Growth and Positive Financial Outlook

Gauzy Ltd. (GAUZ – Research Report) received a Buy rating and a price target from TD Cowen analyst Jeff Osborne today. The company's shares closed ...

Gauzy Ltd. (GAUZ) Initiated with a Buy at TD Cowen

Gauzy stock rises as Stifel initiates coverage with Buy rating

ACGL

ALDX

ALIM

APDN

BBWI

CAKR

COUR

CRWD

CSCO

CTRI

DLTR

DOCU

EQIX

FFIE

FIVE

FLYE

GAUZ

GILD

GPATU

GRND

GTHX

GTLB

HOLO

HOOD

IBTA

INSM

INVH

JUNE

LOAR

LULU

MTEN

NVDA

OSTX

OVID

PGEN

PMAX

PSNY

RAPP

RBRK

SAFE

SAIC

SBUX

SPCE

STTK

SVRA

TSLA

UTHR

VICI

WBTN

ZAPP

Financing

Press Releases

Gauzy Ltd. Announces Pricing of $75 Million Initial Public Offering

Gauzy Ltd. Announces Closing of $75 Million Initial Public Offering

Barclays

TD Cowen

Stifel

Barclays analyst Dan Levy initiates coverage on Gauzy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAUZ#NASDAQ">GAUZ</a>) with a Overweight rating and announces Price Target of $24.

Initiation

Barclays Initiates Coverage On Gauzy with Overweight Rating, Announces Price Target of $24

TD Cowen analyst Jeff Osborne initiates coverage on Gauzy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAUZ#NASDAQ">GAUZ</a>) with a Buy rating and announces Price Target of $24.

TD Cowen Initiates Coverage On Gauzy with Buy Rating, Announces Price Target of $24

Stifel analyst Matthew Sheerin initiates coverage on Gauzy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAUZ#NASDAQ">GAUZ</a>) with a Buy rating and announces Price Target of $18.

Stifel Initiates Coverage On Gauzy with Buy Rating, Announces Price Target of $18

IPOs

Gauzy IPO Shares Open For Trade

Gauzy IPO Indicating $16.50/Share On 95K Shares; IPO Priced At $17/Share On 4.41M Shares

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Gauzy&#39;s ordinary shares are expected to begin trading on the Nasdaq Global Market under the symbol &quot;GAUZ&quot; on June 6, 2024. The offering is expected to close on or about June 7, 2024, subject to satisfaction of customary closing conditions.

The Company intends to use the net proceeds it receives from the offering for the purchase of equipment and materials for the expansion of its production lines, research and development, advertising and marketing, payment of a second earn out payment, working capital, including bonus payments to officers, employees and consultants payable upon the closing of this offering and other general corporate purposes.

Gauzy Prices $75M Initial Public Offering Of 4,411,765 Ordinary Shares At $17/Share

Gauzy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAUZ#NASDAQ">GAUZ</a>) IPO will take place June, 06 on the NASDAQ exchange under the ticker GAUZ.
The company is offering shares at an expected price between $17.00 and $19.00 per share with an insider lock-up period of 180 days ending on December 03, 2024.
See also: <a href="https://www.benzinga.com/calendars/ipos">Benzinga IPO Calendar</a>
<h3>About Gauzy Ltd</h3>
Gauzy Ltd is a fully-integrated light and vision control company, transforming the way we experience our everyday environments.
See also: <a href="https://www.benzinga.com/short-interest">Benzinga's Most Shorted Stocks</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Gauzy Ltd IPOs Tomorrow, Here's What You Need To Know

With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. <a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a>, these enticing companies are scheduled to trade publicly this week.

<ul>
	<li>Waystar Holding Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAY#NASDAQ">WAY</a>) will be trading publicly starting on June 7, 2024. The company&#39;s price band is set between $20.00 and $23.00 with an insider lock-up period of 180 days. Waystar Holding Corp will be offering 45,000,000&nbsp;shares at a per-share value of $21.50.</li>
	<li>Gauzy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAUZ#NASDAQ">GAUZ</a>) becomes publicly listed starting on June 6, 2024. The company has a price range set between $17.00 and $19.00 with a 180-day lockup period. Gauzy Ltd will be offering 4,167,000&nbsp;shares at a per-share value of $18.00.</li>
	<li>Novelis Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVL#NYSE">NVL</a>) will be trading publicly starting on June 6, 2024. The company&#39;s price band is set between $18.00 and $21.00 with an insider lock-up period of 180 days. Novelis Inc will be offering 45,000,000&nbsp;shares at a per-share value of $19.50.</li>
	<li>Fly-E Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) will be trading publicly starting on June 5, 2024. The company&#39;s price band is set between $4.00 and $5.00 with an insider lock-up period of 180 days. Fly-E Group, Inc will be offering 3,000,000&nbsp;shares at a per-share value of $4.50.</li>
</ul>

<h3>Evaluating IPOs</h3>

An initial public offering, or IPO, is the transitional process of a private company deciding to go public and offer shares to investors on an exchange. Typically, IPOs offer companies the ability to build capital. Before a company becomes publicly listed, it must meet SEC requirements and work with investment banks through audits to determine pricing, offering date, and other important data points before the offering.

Companies and investment banks will work to establish a price range that the stock is expected to sell between. This is known as an offering range. Once a company goes public, its stock comes with an opening price. The insider lock-up period is usually a set number of days after an IPO where company insiders, or employees with a 10% or higher stake in their company, cannot sell shares.

This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

A Look At Upcoming IPOs For The Week

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gauzy

News

Latest news for Gauzy (NASDAQ:GAUZ) Stock

Monday, July 01, 2024

Thursday, June 06, 2024

Wednesday, June 05, 2024

Sunday, June 02, 2024